1-2 of 2
Christopher Jenkins, MB
Close
Sort by
Journal Articles

Cellular Aminopeptidase Inhibition as a Target for the Therapy of AML by the Novel Agent CHR 2797.

Christopher Jenkins, MB, BCh, Ken Mills, PHD, Chris Pepper, PHD, Burnett Alan, MB BCh
Journal: Blood
Blood (2007) 110 (11): 1608.
https://doi.org/10.1182/blood.V110.11.1608.1608
Published: 2007
Journal Articles

NF Kappa B as a Therapeutic Target in AML.

Christopher Jenkins, MB, Christopher J. Pepper, PhD, Ken I. Mills, PhD, Alan K. Burnett, MD
Journal: Blood
Blood (2005) 106 (11): 2770.
https://doi.org/10.1182/blood.V106.11.2770.2770
Published: 2005